Background: The impact of hybrid dialysis therapies on amino acid (AA) balance in critically ill patients with acute kidney injury is unknown. Methods: We examined prospectively the AA balance with extended daily diafiltration (EDDF). Results: We studied 7 patients. AA clearances with EDDF ranged from 21.6 ml/min (tryptophan) to 66.9 ml/min (taurine). AA loss was 4.2 (IQR 1.4–12.3) g/day and 4.5% of daily protein intake for patients on enteral nutrition (EN). Percentage AA loss per hour on EDDF was highest for glutamine (32.1%) and lowest for glutamic acid (0.8%). Blood AA levels correlated with corresponding EDDF losses. Median total nitrogen appearance was 25.0 (IQR 20.6–29.3) g/day for patients on EN. This resulted in a negative nitrogen balance of –10.7 (IQR –16.6 to –1.4) g/day, of which 6.5% was attributable to AA loss. Conclusions: AA loss with EDDF was limited, but with much individual variability, and contributed to a strongly negative daily nitrogen balance.

Keywords:
Extended daily diafiltration, Sustained low-efficiency daily dialysis with filtration, Acute kidney injury, Nutrition, Amino acid, Nitrogen balance, Protein catabolism, Protein energy wasting
1.
Fiaccadori E, Parenti E, Maggiore U: Nutritional support in acute kidney injury. J Nephrol 2008;21:645–656.
2.
Bellomo R, Tan HK, Bhonagiri S, Gopal I, Seacombe J, Daskalakis M, Boyce N: High protein intake during continuous hemodiafiltration: impact on amino acids and nitrogen balance. Int J Artif Organs 2002;25:261–268.
3.
Scheinkestel CD, Adams F, Mahony L, Bailey M, Davies AR, Nyulasi I, Tuxen DV: Impact of increasing parenteral protein loads on amino acid levels and balance in critically ill anuric patients on continuous renal replacement therapy. Nutrition 2003;19:733–740.
4.
Druml W: Protein metabolism in acute renal failure. Miner Electrolyte Metab 1998;24:47–54.
5.
Druml W: Nutritional management of acute renal failure. J Ren Nutr 2005;15:63–70.
6.
Hynote ED, McCamish MA, Depner TA, Davis PA: Amino acid losses during hemodialysis: effects of high-solute flux and parenteral nutrition in acute renal failure. JPEN J Parenter Enteral Nutr 1995;19:15–21.
7.
Fiaccadori E, Lombardi M, Leonardi S, Rotelli CF, Tortorella G, Borghetti A: Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: a prospective cohort study. J Am Soc Nephrol 1999;10:581–593.
8.
Baldwin I, Naka T, Koch B, Fealy N, Bellomo R: A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance. Intensive Care Med 2007;33:830–835.
9.
Baldwin I, Bellomo R, Naka T, Koch B, Fealy N: A pilot randomized controlled comparison of extended daily dialysis with filtration and continuous veno-venous hemofiltration: fluid removal and hemodynamics. Int J Artif Organs 2007;30:1083–1089.
10.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P: Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs. The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204–R212.
11.
Uhe AM, Collier GR, McLennan EA, Tucker DJ, O’Dea K: Quantitation of tryptophan and other plasma amino acids by automated pre-column o-phthaldialdehyde derivatization high-performance liquid chromatography: improved sample preparation. J Chromatogr 1991;564:81–91.
12.
Miller L, Houghton JA: The micro-Kjeldahl determination of the nitrogen content of amino acids and proteins. J Biol Chem 1945;159:373–383.
13.
Davenport A, Roberts NB: Amino acid losses during continuous high-flux hemofiltration in the critically ill patient. Crit Care Med 1989;17:1010–1014.
14.
Davies SP, Reaveley DA, Brown EA, Kox WJ: Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Crit Care Med 1991;19:1510–1515.
15.
Frankenfield DC, Badellino MM, Reynolds HN, Wiles CE 3rd, Siegel JH, Goodarzi S: Amino acid loss and plasma concentration during continuous hemodiafiltration. JPEN J Parenter Enteral Nutr 1993;17:551–561.
16.
Kihara M, Ikeda Y, Fujita H, Miura M, Masumori S, Tamura K, Yabana M, Takagi N, Umemura S, Ishii M: Amino acid losses and nitrogen balance during slow diurnal hemodialysis in critically ill patients with renal failure. Intensive Care Med 1997;23:110–113.
17.
Novak I, Sramek V, Pittrova H, Rusavy P, Lacigova S, Eiselt M, Kohoutkova L, Vesela E, Opatrny K Jr: Glutamine and other amino acid losses during continuous venovenous hemodiafiltration. Artif Organs 1997;21:359–363.
18.
Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE: Amino acid loss and nitrogen balance in critically ill children with acute renal failure: A prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000;28:1161–1165.
19.
Wolfson M, Jones MR, Kopple JD: Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 1982;21:500–506.
20.
Btaiche IF, Mohammad RA, Alaniz C, Mueller BA: Amino acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy. Pharmacotherapy 2008;28:600–613.
21.
Avenell A: Glutamine in critical care: current evidence from systematic reviews. Proc Nutr Soc 2006;65:236–241.
22.
Berg A, Norberg A, Martling CR, Gamrin L, Rooyackers O, Wernerman J: Glutamine kinetics during intravenous glutamine supplementation in ICU patients on continuous renal replacement therapy. Intensive Care Med 2007;33:660–666.
23.
Scheinkestel CD, Kar L, Marshall K, Bailey M, Davies A, Nyulasi I, Tuxen DV: Prospective randomized trial to assess caloric and protein needs of critically ill, anuric, ventilated patients requiring continuous renal replacement therapy. Nutrition 2003;19:909–916.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.